Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:51 am
| PEG Ratio | 13.86 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Galaxy Surfactants Ltd operates within the oil drilling and exploration industry, focusing on the production of surfactants and specialty chemicals. As of the latest reporting period, the company’s stock price stood at ₹1,960, with a market capitalization of ₹6,945 Cr, reflecting its solid position in the market. The company reported total sales of ₹4,462 Cr for the fiscal year ending March 2023, which marked a notable increase from ₹3,684 Cr in the previous year. However, the sales witnessed a decline to ₹3,792 Cr in FY 2024, followed by a recovery to ₹4,221 Cr in FY 2025. The trailing twelve months (TTM) sales reached ₹4,791 Cr, indicating a steady upward trajectory in revenue generation. The quarterly sales figures also displayed fluctuations, with the highest quarterly sales of ₹1,278 Cr reported in June 2025, showing resilience in demand despite market volatility.
Profitability and Efficiency Metrics
Profitability metrics for Galaxy Surfactants reflect a mixed performance over recent periods. The company achieved a net profit of ₹381 Cr in FY 2023, which subsequently decreased to ₹301 Cr in FY 2024, before rebounding slightly to ₹305 Cr in FY 2025. The operating profit margin (OPM) stood at 10% in FY 2025, a decline from 13% in FY 2023, suggesting increased operational challenges. The return on equity (ROE) was reported at 12.90%, while the return on capital employed (ROCE) was 16.09%, indicating effective capital utilization. The interest coverage ratio (ICR) of 26.50x exemplifies strong financial health, allowing the company to comfortably meet its interest obligations. However, the cash conversion cycle (CCC) of 73 days indicates room for improvement in working capital management, particularly in reducing inventory and receivables days, which stood at 95 and 59 days, respectively.
Balance Sheet Strength and Financial Ratios
Galaxy Surfactants’ balance sheet demonstrates a healthy financial position, characterized by total assets of ₹3,450 Cr against total liabilities of ₹3,450 Cr, indicating a balanced approach to leveraging. The company reported reserves of ₹2,499 Cr, which supports its equity base and future growth initiatives. With borrowings of ₹268 Cr, the company maintains a low long-term debt-to-equity ratio of 0.01, reflecting conservative financial management. The book value per share has improved significantly to ₹666.44 in FY 2025 from ₹531.04 in FY 2023, showcasing enhanced shareholder value. Financial ratios such as the current ratio at 2.14x and quick ratio at 1.40x signify robust liquidity, enabling the company to meet short-term obligations effectively. However, the price-to-book value (P/BV) ratio of 3.08x suggests that the stock may be perceived as overvalued compared to its book value, warranting careful investor consideration.
Shareholding Pattern and Investor Confidence
The shareholding structure of Galaxy Surfactants reflects strong promoter confidence, with promoters holding 70.91% of the equity as of March 2025. This significant shareholding reinforces investor trust in the company’s management and strategic direction. Foreign institutional investors (FIIs) hold 4.21%, while domestic institutional investors (DIIs) account for 12.90%, indicating a stable institutional interest. The public shareholding stands at 11.96%, showing a balanced distribution of ownership. However, the declining number of shareholders from 64,787 in December 2022 to 49,547 in September 2025 may raise concerns about retail investor participation. The overall investor confidence appears solid, as evidenced by the consistent share price performance amidst market fluctuations, although the declining public shareholding could signal a need for improved engagement with retail investors.
Outlook, Risks, and Final Insight
Looking ahead, Galaxy Surfactants is positioned to capitalize on the growing demand for surfactants and specialty chemicals, driven by increasing applications across various industries. However, the company faces risks, including potential volatility in commodity prices and operational challenges that could affect profit margins. The fluctuating sales figures indicate sensitivity to market conditions, necessitating agile management strategies. Strengths such as a strong balance sheet, high interest coverage ratio, and robust promoter support provide a solid foundation for future growth. Additionally, the company’s strong liquidity ratios suggest it can navigate short-term challenges effectively. Investors should closely monitor operational efficiency improvements and market conditions, as these will significantly influence the company’s performance in the coming years. Overall, Galaxy Surfactants presents a compelling investment opportunity, contingent on its ability to manage risks and leverage growth potential effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Natural Resources Ltd | 1,237 Cr. | 96.3 | 110/16.4 | 778 | 14.1 | 0.00 % | 0.56 % | 2.87 % | 10.0 |
| Dolphin Offshore Enterprises (India) Ltd | 1,789 Cr. | 447 | 550/200 | 33.8 | 75.5 | 0.00 % | 14.7 % | 18.7 % | 1.00 |
| Deep Energy Resources Ltd | 999 Cr. | 312 | / | 694 | 121 | 0.00 % | 0.39 % | 0.35 % | 10.0 |
| Selan Explorations Technology Ltd | 881 Cr. | 580 | 969/475 | 13.4 | 309 | 0.00 % | 22.8 % | 17.2 % | 10.0 |
| Oil India Ltd | 68,326 Cr. | 420 | 492/322 | 11.4 | 346 | 2.74 % | 12.9 % | 13.3 % | 10.0 |
| Industry Average | 31,752.25 Cr | 413.95 | 150.46 | 600.59 | 1.05% | 10.56% | 9.87% | 6.85 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,159 | 1,232 | 1,085 | 980 | 942 | 983 | 940 | 929 | 974 | 1,063 | 1,042 | 1,145 | 1,278 |
| Expenses | 1,011 | 1,100 | 931 | 845 | 819 | 858 | 828 | 827 | 850 | 935 | 936 | 1,018 | 1,154 |
| Operating Profit | 148 | 132 | 154 | 135 | 123 | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 |
| OPM % | 13% | 11% | 14% | 14% | 13% | 13% | 12% | 11% | 13% | 12% | 10% | 11% | 10% |
| Other Income | -2 | 1 | 4 | 7 | 2 | 3 | 6 | 24 | 5 | 9 | 4 | 8 | 11 |
| Interest | 4 | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 7 |
| Depreciation | 19 | 20 | 22 | 23 | 24 | 25 | 25 | 26 | 27 | 28 | 28 | 28 | 29 |
| Profit before tax | 123 | 107 | 131 | 113 | 96 | 98 | 88 | 94 | 99 | 104 | 77 | 100 | 99 |
| Tax % | 18% | 21% | 19% | 20% | 22% | 21% | 19% | 18% | 19% | 19% | 16% | 24% | 20% |
| Net Profit | 100 | 84 | 106 | 91 | 75 | 77 | 71 | 78 | 80 | 85 | 65 | 76 | 79 |
| EPS in Rs | 28.31 | 23.66 | 29.96 | 25.53 | 21.20 | 21.84 | 20.13 | 21.86 | 22.48 | 23.89 | 18.22 | 21.40 | 22.42 |
Last Updated: August 20, 2025, 10:40 am
Below is a detailed analysis of the quarterly data for Galaxy Surfactants Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,278.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,278.00 Cr., marking an increase of 133.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,154.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,018.00 Cr. (Mar 2025) to 1,154.00 Cr., marking an increase of 136.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 127.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Mar 2025) to 10.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 20.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 76.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 22.42. The value appears strong and on an upward trend. It has increased from 21.40 (Mar 2025) to 22.42, marking an increase of 1.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:21 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 | 1,799 | 2,158 | 2,432 | 2,761 | 2,595 | 2,782 | 3,684 | 4,462 | 3,792 | 4,221 | 4,791 |
| Expenses | 1,681 | 1,563 | 1,886 | 2,144 | 2,408 | 2,226 | 2,334 | 3,284 | 3,894 | 3,330 | 3,737 | 4,324 |
| Operating Profit | 190 | 236 | 271 | 288 | 353 | 369 | 449 | 401 | 568 | 462 | 484 | 467 |
| OPM % | 10% | 13% | 13% | 12% | 13% | 14% | 16% | 11% | 13% | 12% | 11% | 10% |
| Other Income | 2 | 6 | 10 | 10 | 5 | 6 | 11 | 13 | 10 | 35 | 26 | 29 |
| Interest | 34 | 34 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 25 |
| Depreciation | 45 | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 115 |
| Profit before tax | 112 | 163 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 355 |
| Tax % | 40% | 37% | 29% | 28% | 31% | 20% | 19% | 20% | 19% | 20% | 20% | |
| Net Profit | 67 | 103 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 286 |
| EPS in Rs | 19.03 | 28.97 | 41.64 | 44.57 | 53.87 | 64.99 | 85.22 | 74.12 | 107.46 | 85.03 | 86.00 | 80.79 |
| Dividend Payout % | 21% | 31% | 14% | 16% | 15% | 22% | 21% | 24% | 20% | 26% | 5% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 53.73% | 43.69% | 6.76% | 20.89% | 20.42% | 31.30% | -12.91% | 44.87% | -21.00% | 1.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10.04% | -36.93% | 14.13% | -0.47% | 10.89% | -44.22% | 57.78% | -65.86% | 22.33% |
Galaxy Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | -10% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 4:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 342 | 412 | 539 | 683 | 841 | 1,032 | 1,266 | 1,539 | 1,847 | 2,144 | 2,327 | 2,499 |
| Borrowings | 451 | 412 | 393 | 348 | 298 | 396 | 289 | 421 | 327 | 187 | 210 | 268 |
| Other Liabilities | 231 | 250 | 315 | 385 | 389 | 348 | 458 | 602 | 518 | 539 | 877 | 975 |
| Total Liabilities | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,778 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1,030 | 1,029 |
| CWIP | 7 | 51 | 10 | 25 | 83 | 66 | 124 | 205 | 139 | 158 | 262 | 290 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 43 | 0 | 0 | 198 | 299 | 385 |
| Other Assets | 594 | 623 | 817 | 980 | 962 | 992 | 1,170 | 1,630 | 1,665 | 1,576 | 1,859 | 2,074 |
| Total Assets | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,778 |
Below is a detailed analysis of the balance sheet data for Galaxy Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,499.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,327.00 Cr. (Mar 2025) to 2,499.00 Cr., marking an increase of 172.00 Cr..
- For Borrowings, as of Sep 2025, the value is 268.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 210.00 Cr. (Mar 2025) to 268.00 Cr., marking an increase of 58.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 975.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 877.00 Cr. (Mar 2025) to 975.00 Cr., marking an increase of 98.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,778.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,450.00 Cr. (Mar 2025) to 3,778.00 Cr., marking an increase of 328.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,029.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,030.00 Cr. (Mar 2025) to 1,029.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 262.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 28.00 Cr..
- For Investments, as of Sep 2025, the value is 385.00 Cr.. The value appears strong and on an upward trend. It has increased from 299.00 Cr. (Mar 2025) to 385.00 Cr., marking an increase of 86.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,074.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,859.00 Cr. (Mar 2025) to 2,074.00 Cr., marking an increase of 215.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,778.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,450.00 Cr. (Mar 2025) to 3,778.00 Cr., marking an increase of 328.00 Cr..
Notably, the Reserves (2,499.00 Cr.) exceed the Borrowings (268.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -261.00 | -176.00 | -122.00 | -60.00 | 55.00 | -27.00 | 160.00 | -20.00 | 241.00 | 275.00 | 274.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 |
| Inventory Days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 |
| Days Payable | 50 | 59 | 63 | 71 | 59 | 60 | 80 | 75 | 52 | 66 | 81 |
| Cash Conversion Cycle | 61 | 64 | 75 | 67 | 65 | 73 | 72 | 91 | 76 | 73 | 73 |
| Working Capital Days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 |
| ROCE % | 23% | 26% | 25% | 28% | 24% | 25% | 19% | 24% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Contra Fund | 51,993,788 | 1.84 | 915.56 | 41,173,788 | 2025-12-08 04:54:22 | 26.28% |
| SBI Balanced Advantage Fund | 46,405,618 | 2.08 | 817.16 | 53,293,368 | 2025-12-08 04:54:22 | -12.92% |
| HDFC Balanced Advantage Fund | 34,000,000 | 0.55 | 598.71 | N/A | N/A | N/A |
| SBI Large Cap Fund | 29,000,000 | 0.92 | 510.66 | N/A | N/A | N/A |
| SBI ELSS Tax Saver Fund | 26,493,555 | 1.44 | 466.53 | N/A | N/A | N/A |
| SBI PSU Fund | 25,750,000 | 7.87 | 453.43 | N/A | N/A | N/A |
| Aditya Birla Sun Life PSU Equity Fund | 18,291,648 | 5.72 | 322.1 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 16,500,000 | 0.97 | 290.55 | 20,000,000 | 2025-12-15 00:55:52 | -17.5% |
| Kotak Flexicap Fund | 15,500,000 | 0.48 | 272.94 | 17,000,000 | 2025-12-15 00:55:52 | -8.82% |
| Kotak Multicap Fund | 15,500,000 | 1.22 | 272.94 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Diluted EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Cash EPS (Rs.) | 117.14 | 113.20 | 131.02 | 94.17 | 106.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Revenue From Operations / Share (Rs.) | 1191.44 | 1070.35 | 1253.95 | 1039.69 | 785.35 |
| PBDIT / Share (Rs.) | 143.88 | 140.39 | 163.08 | 116.56 | 129.67 |
| PBIT / Share (Rs.) | 112.75 | 112.23 | 139.53 | 96.52 | 108.81 |
| PBT / Share (Rs.) | 107.32 | 105.92 | 133.41 | 92.89 | 105.03 |
| Net Profit / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| NP After MI And SOA / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| PBDIT Margin (%) | 12.07 | 13.11 | 13.00 | 11.21 | 16.51 |
| PBIT Margin (%) | 9.46 | 10.48 | 11.12 | 9.28 | 13.85 |
| PBT Margin (%) | 9.00 | 9.89 | 10.63 | 8.93 | 13.37 |
| Net Profit Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| NP After MI And SOA Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| Return on Networth / Equity (%) | 12.90 | 13.83 | 20.23 | 16.69 | 23.21 |
| Return on Capital Employeed (%) | 16.09 | 17.21 | 24.07 | 19.71 | 26.98 |
| Return On Assets (%) | 8.80 | 10.34 | 13.93 | 10.10 | 14.74 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.05 |
| Total Debt / Equity (X) | 0.06 | 0.06 | 0.14 | 0.23 | 0.18 |
| Asset Turnover Ratio (%) | 1.32 | 1.34 | 1.42 | 1.34 | 1.09 |
| Current Ratio (X) | 2.14 | 2.82 | 2.36 | 1.81 | 1.87 |
| Quick Ratio (X) | 1.40 | 1.90 | 1.41 | 0.99 | 1.18 |
| Inventory Turnover Ratio (X) | 6.60 | 4.15 | 4.30 | 4.78 | 4.19 |
| Dividend Payout Ratio (NP) (%) | 20.93 | 4.70 | 33.50 | 5.39 | 16.42 |
| Dividend Payout Ratio (CP) (%) | 15.36 | 3.53 | 27.48 | 4.24 | 13.19 |
| Earning Retention Ratio (%) | 79.07 | 95.30 | 66.50 | 94.61 | 83.58 |
| Cash Earning Retention Ratio (%) | 84.64 | 96.47 | 72.52 | 95.76 | 86.81 |
| Interest Coverage Ratio (X) | 26.50 | 22.22 | 26.64 | 32.16 | 34.25 |
| Interest Coverage Ratio (Post Tax) (X) | 16.84 | 14.46 | 18.56 | 21.45 | 23.51 |
| Enterprise Value (Cr.) | 7197.68 | 7937.75 | 8295.42 | 10453.78 | 9184.23 |
| EV / Net Operating Revenue (X) | 1.70 | 2.09 | 1.87 | 2.84 | 3.30 |
| EV / EBITDA (X) | 14.11 | 15.95 | 14.35 | 25.30 | 19.98 |
| MarketCap / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| Retention Ratios (%) | 79.06 | 95.29 | 66.49 | 94.60 | 83.57 |
| Price / BV (X) | 3.08 | 3.69 | 4.39 | 6.45 | 6.96 |
| Price / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Galaxy Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 117.14. This value is within the healthy range. It has increased from 113.20 (Mar 24) to 117.14, marking an increase of 3.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,191.44. It has increased from 1,070.35 (Mar 24) to 1,191.44, marking an increase of 121.09.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 143.88. This value is within the healthy range. It has increased from 140.39 (Mar 24) to 143.88, marking an increase of 3.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 112.75. This value is within the healthy range. It has increased from 112.23 (Mar 24) to 112.75, marking an increase of 0.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 107.32. This value is within the healthy range. It has increased from 105.92 (Mar 24) to 107.32, marking an increase of 1.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For PBDIT Margin (%), as of Mar 25, the value is 12.07. This value is within the healthy range. It has decreased from 13.11 (Mar 24) to 12.07, marking a decrease of 1.04.
- For PBIT Margin (%), as of Mar 25, the value is 9.46. This value is below the healthy minimum of 10. It has decreased from 10.48 (Mar 24) to 9.46, marking a decrease of 1.02.
- For PBT Margin (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 24) to 9.00, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 8. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.90. This value is below the healthy minimum of 15. It has decreased from 13.83 (Mar 24) to 12.90, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.09. This value is within the healthy range. It has decreased from 17.21 (Mar 24) to 16.09, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 8.80, marking a decrease of 1.54.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.34 (Mar 24) to 1.32, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.82 (Mar 24) to 2.14, marking a decrease of 0.68.
- For Quick Ratio (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.40, marking a decrease of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.60. This value is within the healthy range. It has increased from 4.15 (Mar 24) to 6.60, marking an increase of 2.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.93. This value is within the healthy range. It has increased from 4.70 (Mar 24) to 20.93, marking an increase of 16.23.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has increased from 3.53 (Mar 24) to 15.36, marking an increase of 11.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.07. This value exceeds the healthy maximum of 70. It has decreased from 95.30 (Mar 24) to 79.07, marking a decrease of 16.23.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has decreased from 96.47 (Mar 24) to 84.64, marking a decrease of 11.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 26.50. This value is within the healthy range. It has increased from 22.22 (Mar 24) to 26.50, marking an increase of 4.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.84. This value is within the healthy range. It has increased from 14.46 (Mar 24) to 16.84, marking an increase of 2.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,197.68. It has decreased from 7,937.75 (Mar 24) to 7,197.68, marking a decrease of 740.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.70, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 15.95 (Mar 24) to 14.11, marking a decrease of 1.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For Retention Ratios (%), as of Mar 25, the value is 79.06. This value exceeds the healthy maximum of 70. It has decreased from 95.29 (Mar 24) to 79.06, marking a decrease of 16.23.
- For Price / BV (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has decreased from 3.69 (Mar 24) to 3.08, marking a decrease of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Galaxy Surfactants Ltd:
- Net Profit Margin: 7.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.09% (Industry Average ROCE: 10.56%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.9% (Industry Average ROE: 9.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.1 (Industry average Stock P/E: 150.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gas Transmission/Marketing | GAIL Bhawan 16, Bhikaiji Cama Place, New Delhi Delhi 110066 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sandeep Kumar Gupta | Chairman & Managing Director |
| Mr. Rakesh Kumar Jain | Director - Finance & CFO |
| Mr. Deepak Gupta | Director - Projects |
| Mr. Ayush Gupta | Director - Human Resources |
| Mr. Rajeev Kumar Singhal | Director - Business Development |
| Mr. Sanjay Kumar | Director - Marketing |
| Mr. Akhilesh Jain | Non Official Independent Director |
| Mr. Sanjay Kashyap | Non Official Independent Director |
| Mrs. Kangabam Inaocha Devi | Non Official Independent Director |
| Mr. Yajurvendra Anil Mahajan | Non Official Independent Director |
| Ms. Kamini Chauhan Ratan | Government Nominee Director |
| Mr. Kushagra Mittal | Government Nominee Director |
FAQ
What is the intrinsic value of Galaxy Surfactants Ltd?
Galaxy Surfactants Ltd's intrinsic value (as of 11 January 2026) is ₹1882.03 which is 3.44% lower the current market price of ₹1,949.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,912 Cr. market cap, FY2025-2026 high/low of ₹2,750/1,920, reserves of ₹2,499 Cr, and liabilities of ₹3,778 Cr.
What is the Market Cap of Galaxy Surfactants Ltd?
The Market Cap of Galaxy Surfactants Ltd is 6,912 Cr..
What is the current Stock Price of Galaxy Surfactants Ltd as on 11 January 2026?
The current stock price of Galaxy Surfactants Ltd as on 11 January 2026 is ₹1,949.
What is the High / Low of Galaxy Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Galaxy Surfactants Ltd stocks is ₹2,750/1,920.
What is the Stock P/E of Galaxy Surfactants Ltd?
The Stock P/E of Galaxy Surfactants Ltd is 24.1.
What is the Book Value of Galaxy Surfactants Ltd?
The Book Value of Galaxy Surfactants Ltd is 715.
What is the Dividend Yield of Galaxy Surfactants Ltd?
The Dividend Yield of Galaxy Surfactants Ltd is 1.13 %.
What is the ROCE of Galaxy Surfactants Ltd?
The ROCE of Galaxy Surfactants Ltd is 16.2 %.
What is the ROE of Galaxy Surfactants Ltd?
The ROE of Galaxy Surfactants Ltd is 13.5 %.
What is the Face Value of Galaxy Surfactants Ltd?
The Face Value of Galaxy Surfactants Ltd is 10.0.